Expanding the evidence base for Uromonitor®: updated pooled performance across eight cohorts
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Matthias May, Anton Kravchuk, Ralph M. Wirtz, Thorsten H. Ecke, Axel Heidenreich |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Response to: ‘Expanding the evidence base for Uromonitor®: updated pooled performance across eight cohorts’
par: José Rubio‐Briones
Publié: (2025)
par: José Rubio‐Briones
Publié: (2025)
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial
par: Ingmar Wolff, et autres
Publié: (2024)
par: Ingmar Wolff, et autres
Publié: (2024)
Caution in interpreting the diagnostic superiority of digital Uromonitor in NMIBC surveillance
par: Jinhu Ma, et autres
Publié: (2026)
par: Jinhu Ma, et autres
Publié: (2026)
Response to: “Caution in interpreting the diagnostic superiority of digital Uromonitor in NMIBC surveillance”
par: José Rubio‐Briones
Publié: (2026)
par: José Rubio‐Briones
Publié: (2026)
Trophoblast cell surface antigen‐2: a promising new biomarker and potential therapeutic target in penile squamous cell carcinoma
par: Richard Weiten, et autres
Publié: (2024)
par: Richard Weiten, et autres
Publié: (2024)
External validation of the Uromonitor®‐version 2 urine test as a biomarker for optimisation of non‐muscle‐invasive bladder cancer management
par: José Rubio‐Briones, et autres
Publié: (2025)
par: José Rubio‐Briones, et autres
Publié: (2025)
Cost‐effectiveness analysis of different treatment modalities in BCG ‐unresponsive NMIBC
par: Constantin Rieger, et autres
Publié: (2024)
par: Constantin Rieger, et autres
Publié: (2024)
Differences in mutations across tumour sizes in clear‐cell renal cell carcinoma
par: Steven M. Monda, et autres
Publié: (2024)
par: Steven M. Monda, et autres
Publié: (2024)
Surveillance patterns in non‐muscle‐invasive bladder cancer across risk groups: a real‐world analysis
par: Lisa M. C. van Hoogstraten, et autres
Publié: (2026)
par: Lisa M. C. van Hoogstraten, et autres
Publié: (2026)
First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy
par: Takafumi Yanagisawa, et autres
Publié: (2024)
par: Takafumi Yanagisawa, et autres
Publié: (2024)
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor
par: Maximilian Haas, et autres
Publié: (2024)
par: Maximilian Haas, et autres
Publié: (2024)
Perspectives on technology: Single‐use catheters – evidence and environmental impact
par: Calvin C. Zhao, et autres
Publié: (2024)
par: Calvin C. Zhao, et autres
Publié: (2024)
Bridging the evidence gap in gender‐affirming care: urgent research needs
par: Isabella Dolendo, et autres
Publié: (2025)
par: Isabella Dolendo, et autres
Publié: (2025)
Guideline of guidelines: a critical appraisal of the evidence for PSA retesting intervals
par: Kiana K. Collins, et autres
Publié: (2025)
par: Kiana K. Collins, et autres
Publié: (2025)
Tattoos as a risk factor for bladder cancer: a call for cohort studies
par: Nicolas Kluger, et autres
Publié: (2025)
par: Nicolas Kluger, et autres
Publié: (2025)
Systematic review of PSA reference intervals in the gender diverse population with prostates
par: Rose Hall, et autres
Publié: (2025)
par: Rose Hall, et autres
Publié: (2025)
Population‐based study of disease trajectory after radical treatment for high‐risk prostate cancer
par: Pär Stattin, et autres
Publié: (2024)
par: Pär Stattin, et autres
Publié: (2024)
Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease
par: Sophie L. Harding, et autres
Publié: (2024)
par: Sophie L. Harding, et autres
Publié: (2024)
Hydraulic and malleable female‐to‐male penile implants after phalloplasty in transgender individuals: a retrospective cohort analysis
par: Maya Levy, et autres
Publié: (2025)
par: Maya Levy, et autres
Publié: (2025)
Added value of randomised biopsy to multiparametric magnetic resonance imaging‐targeted biopsy of the prostate in a contemporary cohort
par: Michael Chaloupka, et autres
Publié: (2024)
par: Michael Chaloupka, et autres
Publié: (2024)
Patient‐side performance metrics in robotic surgery: international Delphi‐based consensus from the Junior European Association of Urology Robotic Section/Young Academic Urologists
par: Christoph Würnschimmel, et autres
Publié: (2025)
par: Christoph Würnschimmel, et autres
Publié: (2025)
Curriculum‐based training improves transurethral resection of bladder tumour performance compared to conventional training: the EuropeaN Training in uRologY (ENTRY) project
par: Pietro Diana, et autres
Publié: (2026)
par: Pietro Diana, et autres
Publié: (2026)
Long‐term quality of life in patients with bladder cancer following radical cystectomy
par: Emine Akdemir, et autres
Publié: (2024)
par: Emine Akdemir, et autres
Publié: (2024)
Catheterisation after urethral lengthening in transgender/gender‐diverse individuals: a randomised controlled trial (Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction [ SAFE] )
par: Anastasia Frost, et autres
Publié: (2026)
par: Anastasia Frost, et autres
Publié: (2026)
Staging metastatic urothelial cancer with Nectin‐4 imaging using Gallium‐68‐ N188 PET / CT
par: Matthias Miederer, et autres
Publié: (2025)
par: Matthias Miederer, et autres
Publié: (2025)
Is there any difference between cognitive and fusion transrectal biopsies if performed by residents?
par: Jordi Stira, et autres
Publié: (2025)
par: Jordi Stira, et autres
Publié: (2025)
Aquablation for benign prostatic hyperplasia: real‐world prostate size relevance and bleeding events across 6 years
par: Mario Bitar, et autres
Publié: (2025)
par: Mario Bitar, et autres
Publié: (2025)
Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy
par: Axel S. Merseburger, et autres
Publié: (2024)
par: Axel S. Merseburger, et autres
Publié: (2024)
Comment on ‘Aquablation for benign prostatic hyperplasia: real‐world prostate size relevance and bleeding events across 6 years’
par: Shuo Lin, et autres
Publié: (2026)
par: Shuo Lin, et autres
Publié: (2026)
Non‐infectious adverse events of transperineal prostate biopsies performed under local anaesthesia
par: Maciej Jacewicz, et autres
Publié: (2024)
par: Maciej Jacewicz, et autres
Publié: (2024)
Caval thrombectomy a urological leap into the unknown – a call for action
par: Martin John Connor, et autres
Publié: (2025)
par: Martin John Connor, et autres
Publié: (2025)
Digital pathology‐based artificial intelligence algorithms in prostate cancer: inside the ‘black box’
par: Claire M. de la Calle, et autres
Publié: (2026)
par: Claire M. de la Calle, et autres
Publié: (2026)
Advancing community‐based management of uncomplicated recurrent UTIs in Australia – a pilot study
par: Paul M. Rival, et autres
Publié: (2025)
par: Paul M. Rival, et autres
Publié: (2025)
Patient‐side performance metrics and errors in robotic surgery: Junior‐ European Association of Urology Robotic Urology Section/Young Academic Urologists (J‐ ERUS / YAU) construct validation
par: Christoph Würnschimmel, et autres
Publié: (2026)
par: Christoph Würnschimmel, et autres
Publié: (2026)
Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis
par: Reza Sari Motlagh, et autres
Publié: (2024)
par: Reza Sari Motlagh, et autres
Publié: (2024)
A Prostate Imaging‐Reporting and Data System version 2.1‐based predictive model for clinically significant prostate cancer diagnosis
par: David G. Gelikman, et autres
Publié: (2024)
par: David G. Gelikman, et autres
Publié: (2024)
Clinical determination of the natural distensibility of the human ureter: initial study
par: Sohrab N. Ali, et autres
Publié: (2024)
par: Sohrab N. Ali, et autres
Publié: (2024)
Adeno‐associated virus‐based gene therapy for cystinuria
par: Dazhou Liao, et autres
Publié: (2024)
par: Dazhou Liao, et autres
Publié: (2024)
Defining a new national undergraduate urology curriculum in the UK using consensus‐based methodology
par: Alexander B. C. D. Ng, et autres
Publié: (2026)
par: Alexander B. C. D. Ng, et autres
Publié: (2026)
Artificial intelligence‐based approaches to augmenting and automating surgical training
par: Jasmine Lin, et autres
Publié: (2026)
par: Jasmine Lin, et autres
Publié: (2026)
Documents similaires
-
Response to: ‘Expanding the evidence base for Uromonitor®: updated pooled performance across eight cohorts’
par: José Rubio‐Briones
Publié: (2025) -
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial
par: Ingmar Wolff, et autres
Publié: (2024) -
Caution in interpreting the diagnostic superiority of digital Uromonitor in NMIBC surveillance
par: Jinhu Ma, et autres
Publié: (2026) -
Response to: “Caution in interpreting the diagnostic superiority of digital Uromonitor in NMIBC surveillance”
par: José Rubio‐Briones
Publié: (2026) -
Trophoblast cell surface antigen‐2: a promising new biomarker and potential therapeutic target in penile squamous cell carcinoma
par: Richard Weiten, et autres
Publié: (2024)